Doug Whitney, 76, carries a rare PSEN2 genetic mutation that causes early-onset Alzheimer's but shows no cognitive decline ...

The U.S. Food and Drug Administration has approved a second blood test to improve the detection of Alzheimer’s disease. The ...

Doug Whitney from Seattle appeared to be destined to develop Alzheimer’s disease — but against all genetic odds, he has ...

The FDA has cleared Roche's Elecsys pTau181 test, a blood-based biomarker test for Alzheimer's disease, allowing for earlier ...

The Food and Drug Administration has given approval for a blood test that will rule out if someone has Alzheimer’s disease ...

The new tool is a blood test. The FDA just gave it the green light to help doctors rule out Alzheimer's Disease. Statistics ...

New research from the University of Miami’s Miller School of Medicine has found striking similarities between the brains of ...

Scientists have found a potential new treatment target for Alzheimer’s. It comes after a novel technique improved cognitive ...

Over 7 million Americans are living with Alzheimer’s, which slowly erodes memory, cognitive skills and the ability to perform ...

The prevalence of Alzheimer's disease (AD) is approximately two times higher in African Americans (AA) compared to ...

The FDA approved a blood test developed by Roche and Eli Lilly to aid in the initial assessment for Alzheimer's disease. The test, called Elecsys pTau181, is intended for patients 55 and older ...

A team of researchers from Concordia University and McGill University has developed a "lab-on-a-chip" device that models how ...